18 May 2013
Keywords: gsk, initiates, large-scale, darapladib, chd, trial, uk
Article | 12 January 2009
UK drug major GlaxoSmithKline has initiated the pivotal Phase III STABILITY study to evaluate the efficacy of long-term treatment with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
17 May 2013
© 2013 thepharmaletter.com